the following articles have been added to the
PubMed archives on the wwweb in the past 30 days:

PD: clinical signs and symptoms, neural mechanisms, PET, and therapeutic
interventions.
PMID: 11530892

Updated guidelines for the management of PD.
PMID: 11530583

Subthalamic GAD gene transfer in PD patients who are candidates for DBS.
PMID: 11529246

Mutant beta-spectrin 4 causes auditory and motor neuropathies in quivering
mice.
PMID: 11528393

Automatic orienting of visuospatial attention in PD.
PMID: 11527561

Pattern of intrusions in verbal recall: comparison of AD, PD, and frontal
lobe dementia.
PMID: 11527341

Productive syntax abilities in Huntington's and PDs.
PMID: 11527333

Microglia in neurodegeneration: molecular aspects.
PMID: 11526957

Effects of bilateral subthalamic stimulation on cognitive function in PD.
PMID: 11493162

Subthalamic DBS: neurobehavioral concerns.
PMID: 11493159

DBS in the treatment of PD: A cost-effectiveness analysis.
PMID: 11524476

Fetal cell implantation to treat PD: questions for the future.
PMID: 11523667

Cell transplantation in PD: implications for human clinical trials.
PMID: 11523666

Is transplantation to treat PD dead?
PMID: 11523665

Pathogenesis of idiopathic PD.
PMID: 11523160

Group I mGluR antagonist AIDA protects nigral DA cells from MPTP-induced
injury.
PMID: 11522935

The subthalamic nucleus in PD: somatotopic organization and physiological
characteristics.
PMID: 11522580

Proteasomal inhibition leads to formation of
ubiquitin/alpha-synuclein-immunoreactive inclusions in PC12 cells.
PMID: 11520910

Transfection-enforced Bcl-2 overexpression and an anti-Parkinson drug,
rasagiline.
PMID: 11520893

Does PD Have an Immunological Basis?: The Evidence and its Therapeutic
Implications.
PMID: 11520246

Antagonists reduce levodopa-induced dyskinesia in the mptp-lesioned primate
model of PD.
PMID: 11520128

l-Dopa upregulates the expression and activities of methionine adenosyl
transferase and catechol-o-methyltransferase.
PMID: 11520127

A source of cells for transplantation in PD.
PMID: 11520124

Mitochondrial involvement in brain function and dysfunction: relevance to
aging, neurodegenerative disorders and longevity.
PMID: 11519733

Deficiency and excess of iron in brain function and dysfunction.
PMID: 11519673

Abstracts from the 2nd Congress Deutsche Parkinson March 7-10, 2001.
PMID: 11519488

Function of monoamine neurotransmitter transporters.
PMID: 11519142

Successful treatment of excessive daytime sleepiness in PD with modafinil.
PMID: 11518012

Influence of chronic bilateral stimulation of the subthalamic nucleus on
cognitive function in PD.
PMID: 11518003

Botulinum toxin injections to the calf muscles on freezing of gait in
parkinsonism.
PMID: 11517998

Relationship between the appearance of symptoms and the level of
nigrostriatal degeneration in a progressive MPTP macaque model of PD.
PMID: 11517273

Methamphetamine neurotoxicity: necrotic and apoptotic mechanisms and
relevance to human abuse and treatment.
PMID: 11516769

Basal ganglia dysfunction, working memory, and sentence comprehension in
patients with PD.
PMID: 11516448

(-)-1-(Benzofuran-2-yl)-2-propylaminopentane enhances locomotor activity in
rats due to its ability to induce dopamine release.
PMID: 11516435

Subthalamic nucleus lesions reduce low frequency oscillatory firing of
substantia nigra pars reticulata neurons in a rat model of PD.
PMID: 11516415

Does a vegan diet reduce risk for PD?
PMID: 11516224

Dopamine transporter immunoreactivity in peripheral blood lymphocytes in PD.
PMID: 11515746

Cultured human foetal cerebral cortex, transfected with tyrosine
hydroxylase cDNA, as a source of neural transplant material.
PMID: 11515744

New aspects of physiological and pathophysiological functions of adenosine
A2A receptor in basal ganglia.
PMID: 11515525

Evidence for target-specific outgrowth from subpopulations of grafted human
dopamine neurons.
PMID: 11514985

Comparison of extrapyramidal signs in dementia with lewy bodies and PD.
PMID: 11514644

Electromyographic differentiation of tremors.
PMID: 11514245

Regularity of force tremor in PD.
PMID: 11514241

XANES spectroscopy of a single neuron from a patient with PD.
PMID: 11513007

Magnetisation transfer measurements of the subcortical grey and white
matter in PD with and without dementia and in PSP.
PMID: 11512582

Fatigue among elders in caregiving and noncaregiving roles.
PMID: 11512167

Parkinsonism and occupational exposure to pesticides.
PMID: 11511745

Outcome of unilateral pallidotomy in advanced PD: cohort study of 32 patients.
PMID: 11511714

Treatment of erectile dysfunction with sildenafil citrate (Viagra) in
parkinsonism due to PD or MSA with observations on orthostatic hypotension.
PMID: 11511713

Preclinical syndromes predict dementia: the Sydney older persons study.
PMID: 11511700

Transgenic invertebrate models of age-associated neurodegenerative diseases.
PMID: 11511401

Alpha synuclein aggregation: is it the toxic gain of function responsible
for neurodegeneration in PD?
PMID: 11511392

Rat marrow stromal cells rapidly transduced with a self-inactivating
retrovirus synthesize L-DOPA in vitro.
PMID: 11509954

Determining minimally important differences for the PDQ-39 PD questionnaire.
PMID: 11509307

Neuroendocrinology of ageing.
PMID: 11509304

Twelve-month safety of entacapone in patients with PD.
PMID: 11509081

Spinal movement and performance of a standing reach task in participants
with and without PD.
PMID: 11509070

Levodopa induces dyskinesias in normal squirrel monkeys.
PMID: 11506410

Blinded PET study of dopamine cell implantation for PD.
PMID: 11506400

Metabolic enzyme expression in dopaminergic neurons in PD: an in situ
hybridization study.
PMID: 11506395

PD. Update in diagnosis and symptom management.
PMID: 11505857

Gene transfer of the JNK interacting protein-1 protects dopaminergic
neurons in the MPTP model of PD.
PMID: 11504916

Dynorphins Protect Rat Mesencephalic Dopaminergic Neurons against
Inflammatory Damage.
PMID: 11504811

Differential sensitivity of mesencephalic neurons to inhibition of
phosphatase 2a.
PMID: 11504786

Deep brain stimulator electrodes used for lesioning: proof of principle.
PMID: 11504112

Electrical stimulation of the prelemniscal radiation in the treatment of
PD: an old target revised with new techniques.
PMID: 11504105

Entacapone: new preparation.  Comparative data are lacking.
PMID: 11503812

Frequency of bowel movements and the future risk of PD.
PMID: 11502913

Differential cell death induced by salsolinol with and without copper.
PMID: 11502874

Metoprolol-induced changes in myocardial (123)i-metaiodobenzylguanidine
uptake in PD.
PMID: 11502719

Green tea extract may have neuroprotective effects in PD.
PMID: 11502329

Membrane Binding and Self-Association of alpha-Synucleins.
PMID: 11502187

Does balance control deficit account for walking difficulty in PD?
PMID: 11501233

Motor sequencing deficits in schizophrenia: a comparison with PD.
PMID: 11499989

Paroxysmal hypertensive crises induced by selegiline in a patient with PD.
PMID: 11499649

L-Dopa induces dyskinesia in normal monkeys: behavioural and
pharmacokinetic observations.
PMID: 11498717

Expectation and dopamine release: mechanism of the placebo effect in PD.
PMID: 11498597

Intermuscular coherence in PD: relationship to bradykinesia.
PMID: 11496152

Auditory rhythmicity enhances movement and speech motor control in patients
with PD.
PMID: 11495422

In vitro generation and transplantation of precursor-derived human dopamine
neurons.
PMID: 11494363

Cardiovascular effects of domperidone in patients with PD treated with
apomorphine.
PMID: 11493225

Vascular parkinsonism: a distinct, heterogeneous clinical entity.
PMID: 11493219

Distribution and modulation of histamine h(3) receptors in basal ganglia
and frontal cortex of healthy controls and patients with PD.
PMID: 11493035

Dementia with Lewy bodies.
PMID: 11490548

Prevalence of PD in bulgaria.
PMID: 11490169

Predicting fallers in a community-based sample of people with PD.
PMID: 11490147

Single administration of GDNF into the striatum induced protection and
repair of the nigrostriatal dopaminergic system in a model of
hemiparkinsonism.
PMID: 11490075

Future of neuroprotection in PD.
PMID: 11489679

The use of estrogen in the treatment of PD.
PMID: 11489678

Approaching disturbed sleep in late PD: first step toward a proposal for a
revised UPDRS.
PMID: 11489677

Dystonia and parkinsonism.
PMID: 11489676

Motor fluctuations and dyskinesia in PD.
PMID: 11489675

Levodopa prolongs life expectancy and is non-toxic to substantia nigra.
PMID: 11489674

Functional brain networks in PD.
PMID: 11489673

Molecular neurotoxicological models of Parkinsonism: focus on genetic
manipulation of mice.
PMID: 11489672

Dopamine receptors: understanding the pathophysiology of fluctuations in PD.
PMID: 11489671

5th International Symposium on the Treatment of PD.
PMID: 11489670

Reward signaling by dopamine neurons.
PMID: 11488395

One step back and one, possibly two, steps forward. The different
approaches to PD.
PMID: 11488194

Cortical slow oscillatory activity is reflected in the membrane potential
and spike trains of striatal neurons in rats with chronic nigrostriatal
lesions.
PMID: 11487667

Restorative plasticity of dopamine neuronal transplants depends on the
degree of hemispheric dominance.
PMID: 11487648

Subcutaneous continuous apomorphine infusion in fluctuating patients with PD.
PMID: 11487217

Reduced L-dopa absorption and increased clinical fluctuations in
Helicobacter pylori-infected PD patients.
PMID: 11487216

Which target for DBS in PD? Subthalamic nucleus versus globus pallidus
internus.
PMID: 11487215

Non-motor effects of DBS of the subthalamic nucleus in PD: preliminary
physiological results.
PMID: 11487214

Cytogenetic analysis oxidative damage in lymphocytes of PD patients.
PMID: 11487213

Stimulation of growth hormone release in MSA, PD and idiopathic cerebellar
ataxia.
PMID: 11487211

Amantadine for dyskinesia in patients affected by severe PD.
PMID: 11487209

The parkin gene is not a major susceptibility locus for typical late-onset PD.
PMID: 11487208

Interaction between dopamine and adenosine A2A receptors as a basis for the
treatment of PD.
PMID: 11487207

Proton magnetic resonance spectroscopy (1H-MRS) in de novo PD patients.
PMID: 11487206

DBS of the subthalamic nucleus: selection of patients and clinical results.
PMID: 11487205

Decreased platelet glutamate  uptake and genetic risk factors in patients
with PD.
PMID: 11487204

Alterations in GAD67, dynorphin and enkephalin mRNA in striatal output
neurons following priming in the 6-OHDA model of PD.
PMID: 11487201

Chronic bilateral electrical stimulation of the subthalamic nucleus for
advanced PD.
PMID: 11487200

Hallucinatory psychosis in early-onset PD: drug-induced complication or
psychiatric illness?
PMID: 11487198

The parkin gene and its phenotype.
PMID: 11487197

The status of dopamine nerve terminals in PD and essential tremor.
PMID: 11487195

Perfusion ECD/SPECT in the characterization of cognitive deficits in PD.
PMID: 11487194

The role of language areas in motor control dysfunction in PD.
PMID: 11487193

Efficacy and tolerability of dopamine agonists in a parkinsonian population.
PMID: 11487183

A PET study: the effect of amantadine on the dopaminergic system.
PMID: 11487182

Unawareness of dyskinesias in Parkinson's and Huntington's diseases.
PMID: 11487181

Cell survival and clinical outcome following intrastriatal transplantation
in PD.
PMID: 11487048

janet paterson: an akinetic rigid subtype, albeit perky, parky .
pd: 54/41/37 cd: 54/44/43 tel: 613 256 8340 email: [log in to unmask] .
smail: 375 Country Street, Apt 301, Almonte, Ontario, Canada, K0A 1A0 .
a new voice: the nnnewsletter: http://groups.yahoo.com/group/janet313/ .
a new voice: the wwweb site: http://www.geocities.com/janet313/ .

----------------------------------------------------------------------
To sign-off Parkinsn send a message to: mailto:[log in to unmask]
In the body of the message put: signoff parkinsn